Garcia, Agustin R.
Blanco, Isabel
Ramon, Lluis
Pérez-Sagredo, Jesús
Guerra-Ramos, Francisco J.
Martín-Ontiyuelo, Clara
Tura-Ceide, Olga
Pastor-Pérez, Francisco
Escribano-Subías, Pilar
Barberà, Joan A.
Funding for this research was provided by:
MSD Spain, Spain
Article History
Received: 28 June 2023
Accepted: 5 September 2023
First Online: 15 September 2023
Declarations
:
: Not applicable.
: Not applicable.
: A.R.G. reports consulting fees from Janssen; speaker fees from MSD, Ferrer and Janssen and travel support from Janssen, Menarini, Tuteur and MSD. I.B.V. reports consulting and speaker fees from Janssen, MSD, and Ferrer and travel support from Janssen and MSD. F.P.P. received consulting and speaker fees from Janssen, AOP and MSD. F.J.G.R. reports speaker fees from Janssen, MSD and Ferrer. P.E.S reports consulting fees from Janssen, MSD, Ferrer, GOSSAMER and AOP; speaker fees from Janssen, MSD, Ferrer and AOP; travel support from Janssen and MSD. J.A.B reports consulting fees from MSD, Janssen and Acceleron Pharma; speaker fees from Ferrer, Janssen and MSD; travel support from MSD and Janssen. L.R., J.P.S, C.M.O. and O.T.C. have not reported any potential competing interest.